Hernández Raúl, Plana Liuba, Gómez Leonardo, Expósito Néstor, Valdés Jorge, Páez Rolando, Martínez Eduardo, Beldarraín Alejandro
Department of Purification Development Center for Genetic Engineering and Biotechnology, P.O. Box 6162, Havana 10600, Cuba.
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 25;816(1-2):1-6. doi: 10.1016/j.jchromb.2004.04.020.
Using immunosorbents based upon cyanogen bromide-Sepharose CL-4B, we have examined different ligand densities in coupling of monoclonal antibody (MAb) to find the best performance, for recombinant hepatitis B surface antigen (rHBsAg) purification. Three replicates of 5 and 15 cycles of densities ranges: 2.17-2.19, 3.18-3.62, 4.06-4.17, and 5.13-5.40 mg/ml (control); or 1.81-2.47, 3.17-3.41, 4.16-4.28, and 5.16-5.19 mg/ml (control), respectively were evaluated in terms of binding capacity, antigen recovery, ligand leakage and purity of antigen, and compared to the control. Adsorption and antigen recovery of immunosorbents manufactured were not different statistically, eventhough increased 8.08 and 9.90% at a range of 3.17-3.41 mg/ml. At this range, efficiency expressed as productivity and MAb saving was optimal. Ligand leakage and purity of antigen showed similar behaviour among all densities. Aspects related to ligand density in antigen immunoaffinity purification are discussed.
我们使用基于溴化氰-琼脂糖凝胶CL-4B的免疫吸附剂,检测了单克隆抗体(MAb)偶联时不同的配体密度,以找到用于重组乙型肝炎表面抗原(rHBsAg)纯化的最佳性能。对密度范围为2.17-2.19、3.18-3.62、4.06-4.17和5.13-5.40 mg/ml(对照);或分别为1.81-2.47、3.17-3.41、4.16-4.28和5.16-5.19 mg/ml(对照)的5个和15个循环进行了三次重复,评估了其结合能力、抗原回收率、配体泄漏和抗原纯度,并与对照进行了比较。尽管在3.17-3.41 mg/ml范围内吸附和抗原回收率分别提高了8.08%和9.90%,但所制备的免疫吸附剂的吸附和抗原回收率在统计学上并无差异。在此范围内,以生产率和单克隆抗体节省表示的效率最佳。在所有密度下,配体泄漏和抗原纯度表现出相似的行为。本文讨论了抗原免疫亲和纯化中与配体密度相关的问题。